News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.
Isogenica’s
Latest News
Join Isogenica at Discovery on Target
Isogenica is excited to announce its attendance at Discovery on Target 2021 September 27-30thIsogenica's Associate Director of Antibody Alliances, Marion Cubitt, will be attending Discovery on...
Isogenica-PipeBio Collaboration Press Release
Isogenica announce deployment of the PipeBio Bioinformatic Cloud Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...
Isogenica is attending BIO Digital 2021
Isogenica is excited to announce its attendance at BIO Digital 2021.Isogenica's Director of Business Development Dr David Mead, and Associate Director of Marketing, Dr Mandeep Sehmi will be...
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.
Events
Resources
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
Immunogenicity and humanization of single-domain antibodies
Nature publication: AAV delivery of VHH Intrabodies
De Genst et al showcase the AAV delivery and intracellular in vivo expression of Isogenica’s LlamdA™ VHHs in monomeric and bivalent forms. Interestingly, these VHHs display preferences for distinct...
Webinars
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Isogenica’s
Newsletters
Catch up with Isogenica’s news and activies through the latest Newsletters.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.